Apomorphine-Containing Percutaneous Absorption Type Preparation

Patent No. EP4154885 (titled "Apomorphine-Containing Percutaneous Absorption Type Preparation") was filed by Medrx on May 18, 2021. The application was issued on Aug 6, 2025.

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Aug 20, 2025
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Jul 10, 2025
Decision to grant a European patent
Jul 1, 2025
(Electronic) Receipt
Jul 1, 2025
Filing of the translations of the claims
Jul 1, 2025
French translation of claims
Jul 1, 2025
German translation of the claims
Jul 1, 2025
Letter accompanying subsequently filed items
May 8, 2025
Annex to the communication about intention to grant a European patent
May 8, 2025
Bibliographic data of the European patent application
May 8, 2025
Communication about intention to grant a European patent
May 8, 2025
Intention to grant (signatures)
May 8, 2025
Text intended for grant (clean copy)
May 8, 2025
Text intended for grant (version for approval)
Apr 2, 2025
Examination started
Nov 11, 2024
(Electronic) Receipt
Nov 11, 2024
Amended claims filed after receipt of (European) search report
Nov 11, 2024
Amended claims with annotations
Nov 11, 2024
Amended description filed after receipt of (European) search report
Nov 11, 2024
Amended description with annotations
Nov 11, 2024
Amendments received before examination
Nov 11, 2024
Letter accompanying subsequently filed items
May 28, 2024
Invitation to declare maintenance of the application and to correct deficiencies in the Written Opinion/amend application
May 8, 2024
Communication regarding the transmission of the European search report
May 8, 2024
Document annexed to the Extended European Search Report
May 8, 2024
European search opinion
May 8, 2024
Information on Search Strategy
May 8, 2024
Supplementary European search report
Apr 25, 2024
Search started
Dec 18, 2023
Communication of amended entries concerning the representative
Dec 12, 2023
Letter accompanying subsequently filed items
Dec 12, 2023
Submission concerning change of applicant's representative
Mar 1, 2023
Notification of forthcoming publication
Jan 12, 2023
Communication regarding possible amendment of the application/payment of claims fee
Dec 19, 2022
(Electronic) Receipt
Dec 19, 2022
Abstract
Dec 19, 2022
Claims
Dec 19, 2022
Description
Dec 19, 2022
Drawings
Dec 19, 2022
Request for entry into the European phase
Dec 5, 2022
Copy of the international preliminary report on patentability
Dec 5, 2022
Translation of the international preliminary report on patentability
Sep 30, 2022
Information on entry into European phase
Dec 13, 2021
Priority document (electronically transmitted)
Nov 25, 2021
Copy of the international search report
Nov 25, 2021
Copy of the translated international search report
Nov 25, 2021
International publication pamphlet

EP4154885

MEDRX

Application Number: EP21808425A
Filing Date: May 18, 2021
Status: Granted And Under Opposition; Jul 4, 2025
Publication Date: Aug 6, 2025
External Links: Slate, Register , Google Patents

IP Verse

Apomorphine-Containing Percutaneous Absorption Type Preparation

Patent Summary

Patent Family

Dossier Documents

EP4154885